Vivo Innovation Fund II Holdings, L.P. → BlossomHill Therapeutics, Inc. BLSM

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

3 13D/G filings on this issuer

2 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on BlossomHill Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-08-18	SCHEDULE 13D	ORBIMED ADVISORS LLC	8.90%	2,714,279	view →
2026-08-13	SCHEDULE 13D	Cormorant Asset Management, LP	11.80%	959,090	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →